These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 10369886

  • 1. Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis.
    Jacoby LB, MacCollin M, Parry DM, Kluwe L, Lynch J, Jones D, Gusella JF.
    Neurogenetics; 1999 Apr; 2(2):101-8. PubMed ID: 10369886
    [Abstract] [Full Text] [Related]

  • 2. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
    Koga H, Araki N, Takeshima H, Nishi T, Hirota T, Kimura Y, Nakao M, Saya H.
    Oncogene; 1998 Aug 20; 17(7):801-10. PubMed ID: 9779996
    [Abstract] [Full Text] [Related]

  • 3. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
    Bruder CE, Ichimura K, Tingby O, Hirakawa K, Komatsuzaki A, Tamura A, Yuasa Y, Collins VP, Dumanski JP.
    Hum Genet; 1999 May 20; 104(5):418-24. PubMed ID: 10394935
    [Abstract] [Full Text] [Related]

  • 4. Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2.
    Buckley PG, Mantripragada KK, Díaz de Ståhl T, Piotrowski A, Hansson CM, Kiss H, Vetrie D, Ernberg IT, Nordenskjöld M, Bolund L, Sainio M, Rouleau GA, Niimura M, Wallace AJ, Evans DG, Grigelionis G, Menzel U, Dumanski JP.
    Hum Mutat; 2005 Dec 20; 26(6):540-9. PubMed ID: 16287142
    [Abstract] [Full Text] [Related]

  • 5. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA.
    Hum Mol Genet; 1994 Jan 20; 3(1):147-51. PubMed ID: 8162016
    [Abstract] [Full Text] [Related]

  • 6. Neurofibromatosis 2 phenotypes and germ-line NF2 mutations determined by an RNA mismatch method and loss of heterozygosity analysis in NF2 schwannomas.
    Hung G, Faudoa R, Baser ME, Xue Z, Kluwe L, Slattery W, Brackman D, Lim D.
    Cancer Genet Cytogenet; 2000 Apr 15; 118(2):167-8. PubMed ID: 10748301
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The parental origin of new mutations in neurofibromatosis 2.
    Kluwe L, Mautner V, Parry DM, Jacoby LB, Baser M, Gusella J, Davis K, Stavrou D, MacCollin M.
    Neurogenetics; 2000 Sep 15; 3(1):17-24. PubMed ID: 11085592
    [Abstract] [Full Text] [Related]

  • 10. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK, Lau KM, Tse JY, Lo KW, Wong JH, Poon WS, Huang DP.
    Neurosurgery; 1995 Oct 15; 37(4):764-73. PubMed ID: 8559307
    [Abstract] [Full Text] [Related]

  • 11. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus.
    Sanson M, Marineau C, Desmaze C, Lutchman M, Ruttledge M, Baron C, Narod S, Delattre O, Lenoir G, Thomas G.
    Hum Mol Genet; 1993 Aug 15; 2(8):1215-20. PubMed ID: 8401504
    [Abstract] [Full Text] [Related]

  • 12. Molecular analysis of the NF2 tumor-suppressor gene in schwannomatosis.
    Jacoby LB, Jones D, Davis K, Kronn D, Short MP, Gusella J, MacCollin M.
    Am J Hum Genet; 1997 Dec 15; 61(6):1293-302. PubMed ID: 9399891
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mutations and allelic loss of the NF2 gene in neurofibromatosis 2-associated skin tumors.
    Kluwe L, Friedrich RE, Hagel C, Lindenau M, Mautner VF.
    J Invest Dermatol; 2000 May 15; 114(5):1017-21. PubMed ID: 10771486
    [Abstract] [Full Text] [Related]

  • 15. Truncated NF2 proteins are not detected in meningiomas and schwannomas.
    Den Bakker MA, van Tilborg AA, Kros JM, Zwarthoff EC.
    Neuropathology; 2001 Sep 15; 21(3):168-73. PubMed ID: 11666013
    [Abstract] [Full Text] [Related]

  • 16. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
    Ueki K, Wen-Bin C, Narita Y, Asai A, Kirino T.
    Cancer Res; 1999 Dec 01; 59(23):5995-8. PubMed ID: 10606247
    [Abstract] [Full Text] [Related]

  • 17. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas.
    Leone PE, Bello MJ, Mendiola M, Kusak ME, De Campos JM, Vaquero J, Sarasa JL, Pestana A, Rey JA.
    Int J Mol Med; 1998 May 01; 1(5):889-92. PubMed ID: 9852312
    [Abstract] [Full Text] [Related]

  • 18. Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas.
    Mérel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijlsma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X.
    Genes Chromosomes Cancer; 1995 Jul 01; 13(3):211-6. PubMed ID: 7669741
    [Abstract] [Full Text] [Related]

  • 19. Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas.
    Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM.
    Hum Mol Genet; 1994 Jun 01; 3(6):885-91. PubMed ID: 7951231
    [Abstract] [Full Text] [Related]

  • 20. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
    Seppälä MT, Sainio MA, Haltia MJ, Kinnunen JJ, Setälä KH, Jääskeläinen JE.
    J Neurosurg; 1998 Jul 01; 89(1):36-41. PubMed ID: 9647170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.